Immune-disease-associated variants are enriched in active chromatin regions of T cells and macrophages. However, whether these variants function in specific cell states is unknown. Here we stimulated T cells and macrophages in the presence of 13 cytokines and profiled active and open chromatin regions. T cell activation induced major chromatin remodeling, while the presence of cytokines fine-tuned the magnitude of changes. We developed a statistical method that accounts for subtle changes in the chromatin landscape to identify SNP enrichment across cell states. Our results point towards the role of immune-diseaseassociated variants in early rather than late activation of memory CD4 + T cells, with modest differences across cytokines. Furthermore, variants associated with inflammatory bowel disease are enriched in type 1 T helper (T H 1) cells, whereas variants associated with Alzheimer's disease are enriched in different macrophage cell states. Our results represent an in-depth analysis of immune-disease-associated variants across a comprehensive panel of activation states of T cells and macrophages.
F unctional interpretation of complex-disease-associated variants is challenging because the majority of loci mapped through genome-wide association studies (GWAS) reside in non-coding regions of the genome. Multiple studies have mapped GWAS variants to regulatory elements, such as open chromatin regions and regions tagged by histone modifications [1] [2] [3] [4] [5] , indicating the role of these elements in the regulation of gene expression. The functional effects of non-coding GWAS variants are difficult to deconvolute and may be specific to a particular cell type as well as a cell state, for example, the different stages of cell activation 6 .
Integrating GWAS variants with cell-type-specific chromatin marks can provide insights into disease-causal cell types 1, 4, 7 . This approach has previously identified CD4 + T cells 4, 8 and monocytes 6, 9 as relevant cell types in the pathobiology of various complex immune diseases.
CD4 + T cells are key regulators of the immune response and are crucial in the protection against pathogens. One of the hallmarks of CD4 + T cells is their plasticity; in particular, the ability to differentiate into a range of cell states in response to environmental signals. CD4 + T cells undergo initial activation when they recognize antigens displayed by antigen-presenting cells in the context of co-stimulatory signals. Subsequently, activated T cells undergo proliferation and can be driven to differentiate into distinct T helper phenotypes, depending on the specific cytokines secreted by antigen-presenting cells. The major T helper types include T H 1, T H 2, T H 17 and induced regulatory T cells, each of which has different functions in the immune response. Effector T helper phenotypes are defined by the specific cytokines that they secrete, which in turn instruct other immune cells to acquire different phenotypes. For example, the T H 1 cytokine interferon-γ (IFNγ) polarizes macrophages to a proinflammatory (M1) phenotype with increased pathogen-killing ability, whereas the T H 2 cytokine interleukin-4 (IL-4) induces a tissue-remodeling macrophage phenotype (M2) 10 . As such, the proper differentiation of T cells and macrophages after activation by cytokine signals is a crucial step in eliciting an appropriate immune response.
Although it is established that immune-disease-associated variants localize to chromatin regions that are specific to CD4 + T cells and monocytes, it is not yet known whether immune-diseaseassociated variants are further enriched in chromatin regions that are specific to a particular cytokine-induced cell state. To identify whether immune-disease-associated variants regulate cellular responses to cytokine polarization, we profiled chromatin accessibility using assay for transposase-accessible chromatin using sequencing (ATAC-seq), and active enhancers and promoters marked by histone H3 K27 acetylation (H3K27ac; see Methods) in naive and memory CD4 + T cells as well as macrophages across 55 cell activation states, including early and late responses to activation and cytokine polarization (Supplementary Table 1 ). We developed a statistical method for assessing SNP enrichment in chromatin marks to analyze the effects of immune-disease-associated variants in specific cell states.
Results
Overview of the experimental design. The enrichment of GWAS variants in CD4 + T cells places this cell type at the center of the dysregulated immune responses in disease pathobiology. Key steps in the regulation of the quality of an immune response include the initial activation and differentiation of CD4 + T cells and the subsequent interaction of polarized T cells with downstream effector cells such as macrophages, the activity of which is regulated by T-cell-derived factors. In this study, we focused on dissecting the role of immune-disease-associated risk variants in regulating this Articles Nature GeNetics circuitry. For this purpose, we stimulated monocyte-derived macrophages with T-cell-produced cytokines associated with inflammation and autoimmunity, including IFNγ, TNF, IL-4, IL-23 and IL-26 (Supplementary Table 1 ). As macrophages are part of the fast-responding innate immune system, we measured cytokineinduced activation at 6 h (early response) and 24 h (late response) and profiled the chromatin regulatory landscape. To mimic T cell activation in vitro, we stimulated T cells by delivering T cell receptor and CD28 signals using beads coated with anti-CD3 and anti-CD28 antibodies. In addition, we exposed cells to cytokine cocktails that promote the differentiation towards T H 1, T H 2, T H 17 or induced regulatory T cell fates, or to individual cytokines relevant to autoimmunity (IL-10, IL-21, IL-27, TNF and IFNβ) [11] [12] [13] [14] [15] (Supplementary  Table 1 , see Methods). These stimuli were applied to memory and naive CD4 + T cells, which constitute the two major subsets of CD4 + T cells. We treated naive and memory cells separately because the two subsets differ in their response to stimulation 16 . Given that the response to stimulation develops over time 17 , we profiled T cells during both early and late activation. We defined early response as 16 h, in order to capture the regulation of gene expression before the first cell division. For the late response, we chose 5 d, which is when T cells acquire a defined effector phenotype. At each time point, we profiled the chromatin regulatory landscape by quantifying chromatin activity (H3K27ac ChIPmentation-seq (chromatin immunoprecipitation with sequencing-library preparation by Tn5 transposase)) and chromatin accessibility (ATAC-seq; Fig. 1a ). We then integrated these chromatin profiles with disease-associated variants to identify the most disease-relevant cell states.
Stimulation alters the chromatin landscape of immune cells. We used H3K27ac and ATAC-seq reads to define active chromatin elements (peaks) in the profiled cell types. We detected an average of 25,613 (full range 13,466-38,939) H3K27ac peaks and 26,290 (full range 10,069-58,098) ATAC-seq peaks in T cells, and 34,708 (full range 27,605-42,771) H3K27ac peaks and 73,474 (full range 14,496-129,124) ATAC-seq peaks in macrophages ( Supplementary Fig. 1b ). We detected more peaks in T cells after stimulation compared to unstimulated T cells in the H3K27ac but not in the ATAC dataset (two tailed Student's t-test, P = 0.0001 and P = 0.4 for H3K27ac and ATAC, respectively; Supplementary Fig. 1c ). The identified peaks were highly reproducible across biological replicates ( Supplementary  Fig. 1d ,e). On average, H3K27ac peaks were broader than ATACseq peaks (median size for H3K27ac and ATAC-seq peaks was 3,205 and 410 bp, respectively; Supplementary Fig. 2a ). Furthermore, a larger proportion of ATAC-seq peaks were concentrated at transcriptional start sites (TSSs) compared to H3K27ac, indicating that ATAC-seq was more enriched in promoter regions ( Supplementary  Fig. 2b,c) . We also observed that ATAC-seq peaks were mostly tagged intronic, intergenic and promoter regions, whereas H3K27ac peaks were predominantly present in introns and intergenic regions ( Supplementary Fig. 2c ). Finally, most of H3K27ac peaks overlapped one or more ATAC-seq peaks ( Supplementary Fig. 2d ). Taken together, we conclude that our maps of chromatin activity were of high quality and appropriately captured regulatory elements across the profiled cytokine-induced cell states.
We next investigated the effects of stimulation on the chromatin landscape of naive and memory T cells, as well as macrophages. In general, we observed that the main source of variation correlated with cell type, followed by stimulation ( Supplementary Fig. 3 ), which induced thousands of peaks across all cell types ( Fig. 1b) . However, only a small proportion of peaks were specific to an individual cell state and the majority of peaks were shared between cell states (Fig. 1c ); for example, in T cells, only 2% of H3K27ac and 0.8% of ATAC-seq peaks were specific to the condition. We then assessed the variability in levels of activity of each regulatory element across the cell states by quantifying the coefficient of variation of reads in peaks. We found that quantitative levels of chromatin activity were highly variable across different cytokine-induced cell states and both ATAC and H3K27ac peaks formed a continuous spectrum of variable peaks (Fig. 1c ). The most variable peaks were in proximity to genes that are involved in cell differentiation, whereas the peaks with low variability were in proximity to genes involved in metabolic processes ( Supplementary Fig. 2e ). We also observed that the levels of chromatin accessibility were less variable than those of H3K27ac. For instance, loci that contained hallmark genes for cytokine-induced states showed marked differences in their H3K27ac profiles ( Fig. 1d ) but not in the ATAC-seq profile ( Supplementary Fig. 4 ). This is in line with other reports, which have shown that chromatin activity marked by H3K27ac is more informative in discriminating between closely related cell states than is chromatin accessibility 18, 19 .
Accounting for peak properties refines SNP enrichment. We next assessed whether immune-disease-associated variants were enriched in chromatin elements of any specific cell state in our data. Typically, disease-associated SNP enrichment analyses rely on the presence or absence of overlap between associated variants and regulatory regions 1, 7, 20 . However, in our dataset the majority of peaks were shared across cell states and therefore such a binary SNP-peak overlap approach would be unsuitable to discriminate between the different cellular conditions ( Supplementary Fig. 5 ). A similar observation was previously made using partitioning heritability analysis of neuropsychiatric and metabolic disorders in highly correlated chromatin annotations of different brain regions 5 . To assess the immune disease enrichment across the different T cell and macrophage states, we developed a SNP enrichment method that we call CHEERS (Chromatin Element Enrichment Ranking by Specificity). In addition to SNP-peak overlap, our method takes into account peak properties as reflected by quantitative changes in read counts within peaks, corresponding to variable levels of H3K27ac or chromatin accessibility ( Fig. 2 , see Methods). In brief, we first construct a matrix of quantile-normalized read counts across peaks ( Fig. 2a ). For each peak, we generate specificity scores, for which a high score is assigned to a peak with a higher read count in that cell state compared to all other states. Within each cell state, peaks are then ranked based on their specificity scores (specificity rank; Fig.  2b ). To assess disease-associated SNP enrichment across the different cell states, for each locus we use the index variant and identify variants in strong linkage disequilibrium (LD; R 2 > 0.8). Next, we identify peaks that overlap with the associated variants ( Fig. 2c ). Notably, our method is peak-centric-that is, a peak that overlaps multiple disease-associated variants in a locus contributes to the final cell-type specificity score only once. Alternatively, if the associated variants within a locus intersect multiple peaks, each independent peak contributes to the final enrichment score. We then calculate the mean specificity rank of all peaks that intersect disease-associated variants and infer the significance of the observed SNP enrichment in the cell type by comparing it to a theoretical distribution (see Methods).
We used simulations to assess the sensitivity of CHEERS (see Methods). With more than 23% of variants overlapping the top 10% most cell-type-specific peaks, we observed over 80% power to detect a significant enrichment (P < 0.01). However, at least 78% of SNPs that are needed to map within peaks ranked as low as 60-70% of cell-type-specific peaks to achieve the same power of detecting a significant enrichment ( Supplementary Fig. 6 ). This indicates that CHEERS can detect a significant cell type enrichment only when a sufficient proportion of trait-associated variants overlap peaks with high cell-type specificity. On the basis of the results from these simulations, we concluded that CHEERS is able to identify enrichment in active chromatin elements across closely related cell types. 
CHEERS identifies cell types relevant for immune diseases.
To further validate CHEERS, we used a catalog of 19 primary immune cell types assayed with H3K27ac ChIP-seq as a part of the BLUEPRINT project 3 and tested the enrichment of SNPs associated with 12 complex diseases that have an immune component, including rheumatoid arthritis, allergies, asthma, celiac disease (CED), inflammatory bowel disease (IBD), Crohn's disease, ulcerative colitis, multiple sclerosis, psoriasis, type 1 diabetes, systemic lupus erythematosus and systemic sclerosis. In agreement with previous results, we observed enrichment of rheumatoid arthritis-associated variants in chromatin regions that were active in memory CD4 + T and CD8 + T cells 4,21 ( Supplementary Fig. 7a ). This demonstrated that CHEERS accurately detected enrichment in a dataset of diverse cell types. We observed that risk variants for allergies and asthma were enriched in chromatin regions that were specifically active in memory CD4 + and CD8 + T cells. Moreover, we found enrichment of risk variants for systemic lupus erythematosus and systemic sclerosis in chromatin elements that were specific to B cells ( Supplementary Fig. 7a ), as previously reported 8 .
We found that the immune-mediated diseases that we tested fell into three groups ( Supplementary Fig. 7b ): diseases with a strong T cell component (asthma, allergies, IBD, rheumatoid arthritis, CED and type 1 diabetes), diseases with a strong B cell component (psoriasis, systemic lupus erythematosus and systemic sclerosis) and diseases with both B and T cell components (Crohn's disease, multiple sclerosis and ulcerative colitis). Additionally, we observed that for systemic lupus erythematosus, CHEERS not only recapitulated the previously described enrichment in B cells, but also refined the enrichment further to class-switched B cells, with little signal in unswitched B cells ( Supplementary Fig. 7a ). On the basis of these results, we conclude that CHEERS is also suitable for the identification of enrichment of trait variants in active chromatin elements across related cell types.
Finally, to further validate CHEERS we used the Roadmap Epigenomics dataset, which contains H3K27ac data from a collection of 50 tissues and cell types, including a variety of non-immune tissues (https://egg2.wustl.edu/roadmap/data/byFileType/). We included three diseases in this analysis: multiple sclerosis, coronary artery disease and Parkinson's disease ( Supplementary Fig. 7d ). We identified strong enrichment of GWAS loci for Parkinson's disease in cell types from different brain regions and the adrenal gland. By contrast, GWAS loci for multiple sclerosis showed significant enrichment in immune cell types. This showed that CHEERS can correctly disentangle the biological differences between multiple sclerosis and Parkinson's disease even though both affect the central nervous system. Moreover, we identified a significant enrichment of risk variants for coronary artery disease in chromatin regions that were specific to the aorta (top enrichment), lungs and multiple muscle tissues (both skeletal and smooth). Overall, these results demonstrate that CHEERS was able to identify relevant cell-type-specific enrichment of GWAS loci for both immune and non-immune traits.
Refining cell states relevant for immune diseases. We next tested whether GWAS variants associated with immune-mediated diseases were enriched in active chromatin regions that are specific to the cytokine-polarizing cell states in our dataset. In addition, we included GWAS variants associated with Alzheimer's disease, as microglia-which are a subtype of macrophages-have been suggested to play a role in this disease 22, 23 . The tested traits included from 17 to 132 associated loci, resulting in a range of 25 (asthma) to 317 (IBD) SNP-peak overlaps that contributed to the final enrichment scores. Variants associated with multiple sclerosis, rheumatoid arthritis, CED, IBD, Crohn's disease, ulcerative colitis, psoriasis, type 1 diabetes, allergy and asthma were predominantly enriched in T cells, which is in line with the observations from the BLUEPRINT data ( Fig. 3 ). This enrichment was particularly strong in chromatin regions that are specifically active during early activation of memory T cells (16 h; Fig. 3 ). We did not observe significant differences between early and late activation of T cells, either in the number or the quality (that is, q value) of H3K27ac peaks ( Supplementary  Fig. 1 ). Additionally, resting memory T cells-which were cultured without any stimulus-showed no significant enrichment in any of the tested diseases, suggesting that it is specifically the regulation of T cell activation that drives these signals. We did not observe T cell enrichment in control traits such as coronary artery disease and low-density lipoprotein cholesterol (Fig. 3) . Finally, we found that enrichment was predominantly driven by peaks that were proximal to the TSS ( Supplementary Fig. 8) .
The observed enrichment of immune variants in early memory T cell activation was driven by a group of H3K27ac peaks that were highly specific to this cell state ( Fig. 4a, Supplementary Fig. 9 ). For example, a group of GWAS variants for allergies overlapped a peak close to the chemokine (C-C motif) ligand 20 (CCL20) gene, which showed higher levels of acetylation specifically during early activation of memory T cells (Fig. 4b ). Allergy-associated variants also mapped within a smaller group of peaks that were active specifically during early activation of naive T cells, explaining the secondary enrichment in activated naive T cells (Fig. 4a) . A proportion of immune-disease-associated variants also mapped to peaks that were specific to early activation of both naive and memory CD4 T cells. For instance, rheumatoid arthritis-associated variants overlapped a peak near the acyl-CoA oxidase-like protein (ACOXL) gene, which is involved in T cell metabolism (Fig. 4b) . Collectively, genes near peaks that drive the enrichment in early activation of memory T cells across all diseases were enriched in pathways such as T cell activation, T cell differentiation and leukocyte activation (Fig. 4d ). This suggests that immune-disease-associated variants overlap enhancers and promoters that regulate gene expression programs during early activation of memory T cells.
Overall, we observed that individual cytokine conditions and late stages of T cell activation were enriched among a few selected T cell states and diseases. For example, multiple sclerosis-associated variants were significantly enriched after IL-27 stimulation in early memory T cell activation (P = 5.4 × 10 −10 ). This is concordant with previous studies that reported elevated levels of IL-27 in the cerebrospinal fluid of patients with multiple sclerosis 24, 25 . Among the late activation states, naive T cells polarized with T H 1 cytokines were of particular note as they were strongly enriched for IBD, Crohn's disease, ulcerative colitis and CED (P = 9.92 × 10 −9 , P = 1.11 × 10 −7 , P = 4.89 × 10 −4 and P = 1.01 × 10 −5 , respectively). The H3K27ac peaks that intersect risk variants for these diseases with high specificity in T H 1 cells were in close proximity to genes that are involved in T H 1 biology, such as IFNγ and IL-12R (Fig. 4c ). Furthermore, collectively these genes were enriched in hallmark pathways of T H 1 cells such as IFNγ, IL-12 and JAK-STAT signaling (Fig. 4d) .
Across all tested traits, only Alzheimer's disease-associated variants were significantly enriched in macrophages (Fig. 3) ; however, we did not find any individual cytokine condition that was more significant than others. Genes in proximity to peaks that overlap Alzheimer's disease-associated variants driving the macrophage signal were enriched in pathways, such as regulation of amyloid-β clearance and amyloid-β formation-processes that have been extensively studied in the context of Alzheimer's disease pathology (Fig. 4d) .
Finally, we observed that in the ATAC-seq data, the enrichment results were less significant ( Supplementary Fig. 10a ), although the global patterns of the most relevant disease-associated cell states replicated those of the H3K27ac data ( Supplementary Fig. 10b ). This agreed with our observations that ATAC-seq peaks were less variable. Similarly to H3K27ac data, ATAC-seq enrichments were mostly driven by the peaks that were proximal to a TSS ( Supplementary Fig. 11 ).
In summary, our results suggest that variants associated with immune-mediated diseases play a role in genetic regulation during the early activation of CD4 + T cells, predominantly in memory T cells. We found that individual cytokine-induced cell states were enriched for variants associated with specific immune diseases. For example, risk variants for IBD, its two subphenotypes (ulcerative colitis and Crohn's disease), as well as CED were enriched in chromatin elements specific to late activation of naive T cells with T H 1 polarizing cytokines. Our approach provides a framework for identifying disease relevant cell types and cell states and will inform the design of subsequent large-scale studies for functional interpretation of GWAS variants for complex immune diseases.
Discussion
Identifying the most relevant cellular context in which disease-associated variants function is critical for designing meaningful functional follow-up studies. Here, we used an in vitro system to identify cytokine-induced cell states that are relevant for the pathobiology of immune-mediated diseases. We found that most changes in the chromatin landscape of CD4 + T cells resulted from T cell receptor and CD28 stimulation alone, whereas the presence of specific cytokines had a modulatory effect on the levels of these changes. As a consequence, T cell states had very similar chromatin landscapes and currently available SNP enrichment methods could not distinguish between them. To address this, we developed CHEERS, a statistical method that takes into account quantitative changes in chromatin activity.
Using CHEERS, we were able to refine the enrichment of immune-disease-associated variants observed in previous studies 7, 21, 26 to specific cellular contexts. For 10 of the 12 immune diseases that we tested, we show that the associated variants were enriched during early activation of memory CD4 + T cells. A recent study, which profiled open chromatin regions across subsets of immune cells in resting and stimulated states, also identified enrichment of immune-disease-associated variants in T cell activation 27 . Our study now provides further evidence for the importance of this cell type in the biology of complex immune-mediated diseases and builds a case for dysregulation of specific cellular processes.
Immunophenotyping studies have identified elevated cytokine levels in patients with immune diseases and this has subsequently led to the development of disease-modifying therapies that target different cytokines [28] [29] [30] [31] . This implies that effector T cells (corresponding to 5-d stimulations in our dataset) and the cytokines that they secrete drive autoimmune inflammation. By contrast, our results suggest that GWAS variants for immune-mediated diseases affect regulation mostly during the initial phase of memory T cell activation, but less so during the effector response seen at a later time point. Therefore, although cytokine-induced cell states could be key in the later stages of pathologic inflammation, they might not be triggering a disease. This emphasizes the importance of tight regulation of T cell activation, suggesting that many subtle effects of immune variants lead to dysregulated early cell responses. This agrees with observations from severe immune disorders in which, for instance, deficiency in the expression of one of the main regulators of T cell activation, CTLA-4, has been associated with the development of autoimmune diseases due to uncontrolled T cell activation [32] [33] [34] [35] . Furthermore, it is worth noting that immune-mediated diseases are more often diagnosed in adults, which correlates with a shift in the frequency of T cells from naive to predominantly memory T cells. Therefore, our results suggest that focusing on the regulation of early activation of memory CD4 + T cell may provide an important axis for the development of new treatment options.
In addition to early activation of memory CD4 + T cells, we observed selected diseases for which the associated variants were enriched in distinctive cytokine-polarized cell states. For example, IBD, Crohn's disease, ulcerative colitis and CED risk variants were highly enriched in T cells polarized with T H 1 cytokines. This agrees with previous findings from immunophenotyping studies that have shown that lamina propria T cells express high levels of STAT4, T-bet and IL-12R, which are all induced by T H 1 polarizing cytokines 36 . This could indicate that a proportion of IBD variants regulate the function of T H 1 cells, suggesting the involvement of this cell type in the development of IBD. Another example is asthma, for which we detected enrichment in naive T cells polarized towards the T H 2 phenotype. 
Fig. 4 | Example loci that drive the enrichment of SNPs associated with immune diseases in cytokine-induced cell states. a,
Loci that drive the enrichment of allergy-associated variants in early activation of memory T cells. Each row corresponds to a H3K27ac peak that intersects GWAS variants for allergy, whereas each column corresponds to a different cytokine-induced cell state. Shades of blue represent how specific each peak is to each cell state (specificity rank of the peak normalized to the mean specificity rank of all peaks). Different boxes highlight groups of peaks specific to different cell states. b, Read pileups at the selection of H3K27ac peaks that drive the enrichment of allergy-associated and rheumatoid arthritis-associated variants in early T cell activation. Genomic coordinates (GRCh38) for each gene are labeled. H3K27ac tracks were generated after merging three biologically independent samples per cell state. c, Read counts at a selection of H3K27ac peaks, driving the enrichment of IBD-associated variants in T H 1-stimulated T cells. Genomic coordinates (GRCh38) for each gene are labeled. H3K27ac tracks were generated after merging three biologically independent samples per cell state. d, Pathway enrichment analysis using all the genes in proximity to H3K27ac peaks driving the enrichment of GWAS variants in early T cell activation (all immunemediated diseases), T H 1 cells (IBD and CED) and macrophages (Alzheimer's disease). To determine these enrichments, we selected peaks with the top 10% specific peaks at the enriched cell states and assigned them to the closest gene. P values were calculated using g:ProfileR with default parameters. The number of genes used for enrichment analysis was 215 for memory CD4 + T cells (early activation), 27 for macrophages and 53 for CD4 + T cells polarized towards T H 1.
Across the tested immune diseases, we did not observe a significant enrichment in the macrophage stimulatory cell states, suggesting that autoimmune inflammation is mostly driven by T cells. By contrast, variants associated with Alzheimer's disease point to a crucial role of macrophages in the disease. Recent studies have highlighted the role of microglia in Alzheimer's disease 22, 23, 37 , a type of resident macrophage in the central nervous system. Our results suggest that a proportion of Alzheimer's disease-associated variants could be studied in an in vitro model of monocyte-derived macrophages. This could have important implications, as cells from the central nervous system are challenging to collect. Finally, the lack of stratification of Alzheimer's disease-associated variants between the different cytokine-induced macrophage states could indicate that some Alzheimer's disease-associated variants might regulate moregeneral functions of the macrophage lineage. These functions could be closely linked to amyloid-β clearance, as suggested by our results.
Our study systematically profiles changes in the chromatin regulatory landscape that are induced by cytokines during activation of human immune cells. This provides a valuable resource to identify appropriate cell models for studying how genetic variants lead to diseases.
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Methods Sample processing and cell activation. Blood samples were obtained from nine healthy individuals. Cellular conditions within each cell type (naive CD4 T cells, memory CD4 T cells and monocyte-derived macrophages) were derived from three donors. The human biological samples were sourced ethically and their research use was in accordance with the terms of the informed consents under an IRB/EC-approved protocol (15/NW/0282). Peripheral blood mononuclear cells were isolated using Ficoll-Paque PLUS (GE Healthcare) density gradient centrifugation. Naive and memory CD4 + T cells were isolated from peripheral blood mononuclear cells using the EasySep naive CD4 + T cell isolation kit and memory CD4 + T cell enrichment kit (StemCell Technologies) according to the manufacturer's instructions. T cell purity was above 94% in all samples ( Supplementary Fig. 1a ). T cells were stimulated with anti-CD3/anti-CD28 human T-activator Dynabeads (Invitrogen) at 1:2 bead:T cell ratio. Cytokines were added at the same time as the stimulus and cells were collected after 16 h and after 5 d (the list of cytokines and their concentrations are provided in Supplementary Table 1 ).
Monocytes were isolated using the EasySep monocytes isolation kit according to the manufacturer's instructions. To generate macrophages, monocytes were plated in a 100 mm × 20 mm dish and cells were treated with 800 U ml −1 macrophage colony-stimulating factor (PeproTech) for 7 d ( Supplementary  Fig. 1a ). Following macrophage differentiation, cells were stimulated with cytokines for 6 h and 24 h (the list of cytokines and their concentrations are provided in Supplementary Table 1 ).
Flow cytometry. Cells were analyzed with an BD LSR Fortessa. All data obtained by flow cytometry were analyzed by FlowJo v.9.9.6 (TreeStar).
ChIPmentation-seq.
To profile active enhancers and promoters, cells were washed with RPMI and Dynabeads were removed using a DynaMag magnet (Thermo Fisher). Next, the cells were resuspended at 1 × 10 6 cells ml −1 in FACS buffer (PBS buffer supplemented with 10% fetal calf serum and 1 mM EDTA) and chromatin was cross-linked by adding 1% formaldehyde and incubating at 37 °C for 5 min. To quench the reaction, we added glycine and washed the cells in cold PBS buffer. Cross-linked cell pellets were frozen in liquid nitrogen and stored at −80 °C until further processing.
To perform ChIPmentation, cross-linked cell pellets were thawed and processed using the iDeal ChIP-seq kit for histones (Diagenode) according to the manufacturer's instructions. In brief, cells were lysed and sonicated, and the resulting material was used for immunoprecipitation. Sonication was performed using a Bioruptor Pico (Diagenode), with six sound pulse cycles of 30 s each. For immunoprecipitation, we used ChIP-grade antibodies specific to human H3K27ac histones (Diagenode). A negative control that did not undergo immunoprecipitation (input) was also generated for each cell type. After immunoprecipitation, the recovered chromatin fragments were tagmented as previously described 38 . In brief, 2 μl of immunoprecipitated material was resuspended in 30 μl ChIP-seq buffer (Diagenode) supplemented with 1 μl Tn5 (Illumina). Samples were then reverse cross-linked using the iDeal ChIP-seq kit for histones according to the manufacturer's instructions. The resulting DNA was purified using SPRI magnetic beads (AMPure XP A63881 Beckman Coulter). Enrichment of active chromatin regions was verified by qPCR.
Sequencing libraries were constructed from the obtained material using the Nextera DNA library preparation kit according to the manufacturer's instructions. In brief, DNA was amplified by PCR and fragments of inappropriate sizes were removed using Agencourt AMPure XP beads (BD). Finally, samples were pooled and loaded into an Illumina HiSeq 2500 instrument for paired-end sequencing. To minimize batch effects, samples were randomized before sequencing. We obtained an average of 63 million paired-end reads per sample.
ATAC-seq.
To profile open chromatin regions, stimulated cells were washed with RPMI and Dynabeads were removed using a DynaMag magnet (Thermo Fisher). Next, tagmentation was performed using the fast ATAC protocol 39 . In brief, 50,000 cells were washed in cold PBS buffer and resuspended in 50 μl of Nextera tagmentation buffer supplemented with 0.01% digitonin and 2.5 μl Tn5 transposase (Nextera). Samples were then incubated at 37 °C and 800 r.p.m. for 30 min. After tagmentation, DNA was purified using MinElute PCR columns (Qiagen) according to the manufacturer's instructions and stored at −80 °C until library preparation.
Sequencing libraries were generated from tagmented DNA using the Nextera DNA library preparation kit according to the manufacturer's instructions. In brief, DNA was amplified by PCR and fragments of inappropriate sizes were removed using Agencourt AMPure XP beads (BD). Finally, samples were pooled and loaded into an Illumina HiSeq 2500 for paired-end sequencing. To minimize batch effects, samples were randomized before library preparation and before sequencing. We obtained an average of 58 million paired-end reads per sample.
ATAC-seq and ChIPmentation-seq analysis.
We assessed the quality of the reads using fastx and trimmed the adapters using skewer (v.0.2.2) 40 . We then mapped reads to the human reference genome GRCh38 using bwa mem (v.0.7.9a) 41 , only keeping uniquely mapped reads. We also removed PCR duplicates and mitochondrial reads from ATAC-seq data using samtools (v.0.1.9) 41, 42 . This resulted in the final BAM files containing uniquely mapped, non-mitochondrial reads that were used for peak calling. Finally, we calculated insert size distributions using PICARD tools (v.2.6.0) to remove samples with over-or undersonicated chromatin, and samples with skewed distributions of insert sizes.
Peaks were called using MACS2 (v.2.1.1) 43 . For ATAC-seq, peaks were called using the standard MACS2 model and specifying --nomodel --shift -100 --extsize 200 on fragment BED files (both reads of a pair were merged into a single fragment, as the -f BAMPE option does not work when shift is specified). For H3K27ac, ChIPmentation peaks were called on BAM files specifying -f BAMPE --broad --broad-cutoff 0.1 --nomodel --extsize 146. For each cell-type-stimulation pair we used an input from the same condition (for example, all memory 16H samples were called using input generated from memory 16H cells). We kept peaks that had values of q < 10 −2 for H3K27ac data and q < 10 −4 for ATAC-seq data. Finally, to ensure that the downstream analysis was carried out using high-quality data, we filtered out peaks that were present in less than two biological replicates within a condition (we refer to these as the confident peak set). The peak overlap between the assays was calculated using bedtools intersect (v.2.22.0), while the distance of a peak to the closest TSS and peak annotation was assessed using Homer's annotatePeaks.pl (v.4.10.3).
To assess the quality of our data, we calculated the fraction of reads in peaks (FRiP). We excluded 7 H3K27ac samples with FRiP < 10% and 15 ATAC-seq samples with FRiP < 5%. The average q values were 13.1 and 5.3 for ATAC-seq and ChIPmentation, respectively. The total number of samples remaining in our dataset after this quality control was 173 in the H3K27ac dataset and 168 in the ATAC-seq dataset. In addition, samples with skewed distribution of insert sizes, or <10 million read pairs that passed quality control and <10,000 peaks were removed from the downstream analysis. Finally, we assessed peak reproducibility per cell state and kept only peaks that exist in at least two biological replicates of any condition. We also removed peaks on Y chromosome and alternative contigs. This generated a final set of H3K27ac and ATAC peaks that were used for GWAS enrichment analysis.
Additionally, two H3K27ac and three ATAC-seq samples that did not cluster with the corresponding group in principal component analysis were discarded from further analysis. After quality-control filtering, we kept a total of 173 H3K27ac and 168 ATAC-seq samples.
To define differentially accessible regions and differentially modified histone regions, we used DESeq2 44 . We compared all conditions to the resting state or to T H 0 and used a Benjamini-Hochberg controlled false discovery rate of 10% and an absolute fold change ≥ 1.
BLUEPRINT ChIP-seq analysis. Raw data for H3K27ac ChIP-seq of 19 immune cell types were obtained from the BLUEPRINT consortium 3 . These files were processed following the same data analysis pipeline as described above.
GWAS data processing. GWAS variants associated with 16 complex diseases at the genome-wide significance threshold were obtained from previous studies. We included in our analysis: allergies 45 , Alzheimer's disease 46 , asthma 47 , CED 48 , coronary artery disease 49 , levels of low-density lipoprotein 50 , Crohn's disease 51 , IBD 51 , multiple sclerosis 52 , Parkinson's disease 53 , psoriasis 54 , rheumatoid arthritis 26 , systemic lupus erythematosus 55 , systemic sclerosis 56 , type 1 diabetes 57 and ulcerative colitis 51 . Variants mapping to the HLA region were removed. SNPs were finally pruned by LD using a 50-kb window and R 2 < 0.1. Variants with a minor allele frequency that was less than 5% were excluded. The final list of variants was used as an input for SNP enrichment analysis.
Disease enrichment with GoShifter. We ran GoShifter on ATAC and H3K27ac peaks as described previously 7 . We ran 10,000 permutations. Command used: python goshifter.py -s SNP_list -a annotation/file/path -p 10000 -l LD/file/path -o output_name.
CHEERS.
Quality-controlled BAM files corresponding to biological replicates of the same condition were merged using samtools. Then, for each cell type and cell state we quantified the number of reads within the merged peak regions using featureCounts (v.1.5.1) 58 . We normalized each peak to the library size by scaling the peak read counts to the sample with the highest count of informative sequence reads:
where C is the number of reads falling within peak j in cell state i.
To ensure that our analysis was not confounded by the low confidence peaks, we removed the bottom tenth percentile of peaks with the lowest read counts and obtained a final count of 127,723 peaks for H3K27ac ChIPmentation and 136,692 for ATAC-seq.
To compare the peaks across the cell types and cell conditions, we also quantile normalized the library size-corrected peak counts. We then transformed the read count of each peak into a score that reflects cell-type specificity (specificity score). For the specificity score, we divided the normalized read counts of each peak Articles Nature GeNetics in each condition by the Euclidean norm for that peak across all conditions, as described in the following formula:
where S i,j is the specificity score and Z i,j is the normalized number of reads within peak j in condition i. This score is a number from 0 to 1, where 1 means that a peak has high read counts in only one cell state and 0 means the peak shows no read in that cell state. Then, within each cell state, peaks were ranked by specificity score from the highest to the lowest score, for which the peak that was the least specific to the cell state was ranked 1. If multiple peaks have equal specificity scores, the same lower rank is assigned to all of them.
To test for disease SNP enrichment, we take all of the index variants, identify variants in LD (r 2 > 0.8) and overlap them with peaks. Notably, our method is peak-centric, that is, a peak that overlaps multiple disease-associated variants in a locus contributes to the final cell-type specificity score only once. On the other hand, if within a locus the associated variants intersect multiple peaks, each independent peak contributes to the final enrichment score. We then calculate the mean specificity rank of all peaks that intersect disease-associated variants. We inferred the significance of the observed enrichment by fitting a discrete uniform distribution. Within each cell state, all ranks (1, 2, 3…N) can be observed with an equal probability and thus follow a discrete uniform distribution (Kolmogorov-Smirnov test, P = 1) with mean (μ):
and variance:
where max and min are the maximal and minimal ranks in the dataset. When we substitute max with number of peaks (N) and min with the minimal rank (1), we obtain the following formula:
which, under the central limit theorem converges to:
where σ 2 I is the variance of the mean of the n peak ranks overlapping the GWAS SNPs, assuming that these overlap at random.
Finally, we calculate P values as:
where the Φ xÀμ σ À Á I is a cumulative normal distribution for x / Nðμ; σ 2 Þ I ; x is the observed rank, and μ and σ are the expected values under the null hypothesis that all ranks occurred as random.
To ensure that this method accounts for any possible unidentified properties of the data, such as correlations, we also assessed the significance of the enrichment using an empirical, permutation-based strategy. For this strategy, within each of the tested cell states, we randomly sampled sets of peaks, matching to the number of peaks that overlapped GWAS variants, and calculated the mean of their ranks. We repeated this process N times, assessed the frequency at which the mean of the permuted ranks was greater or equal to the mean of the observed ranks, and derived an empirical P value:
where N is the number of permutations. Both approaches yielded similar results although the P values from CHEERS were not limited by the number of permutations (R 2 = 0.96, P < 2.2 × 10 −16 ).
Power calculations for CHEERS. To estimate the power of CHEERS, we simulated 100 SNP-peak overlaps and tested for enrichment. Each simulation was repeated 100× and power was estimated as the percentage of simulations that yielded a significant enrichment (P < 0.01). We designed the simulations such that a given percentage of SNPs (ranging from 0% to 100%), but not the remaining SNPs, always overlapped with peaks in the top tenth percentile of specificity. Finally, to test how specific the peaks needed to be for our method to detect enrichment, we repeated the simulations at lower specificity percentiles.
Pathway enrichment analysis. Pathway enrichment analysis and statistics were performed using g:ProfileR (v. 0.6.1).
